Search research articles
Contact Us
Filters
Showing results (31-40 of 56) with videos related to
Page
of 6
Sort By:
Journal of Medical Economics
|
May 14, 2013
Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia
John M Kane, Raymond Sanchez, Joan Zhao, et al.
The Journal of Clinical Psychiatry
|
August 25, 2015
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study
Michael E Thase, James M Youakim, Aleksandar Skuban, et al.
Journal of Medical Economics
|
October 28, 2014
Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis
John M Kane, Cathy Zhao, Brian R Johnson, et al.
The Journal of Clinical Psychiatry
|
October 6, 2007
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline
Gary S Sachs, Bruce D Gaulin, Rolando Gutierrez-Esteinou, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 2, 2009
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study
Allan H Young, Dan A Oren, Adam Lowy, et al.
The Journal of Clinical Psychiatry
|
June 16, 2012
Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study
John M Kane, Raymond Sanchez, Pamela P Perry, et al.
The Journal of Clinical Psychiatry
|
October 27, 2007
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo
Paul E Keck, Joseph R Calabrese, Roger S McIntyre, et al.
Journal of Clinical Psychopharmacology
|
April 7, 2017
Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores
Zahinoor Ismail, Timothy Peters-Strickland, Maia Miguelez, et al.
The Journal of Clinical Psychiatry
|
August 25, 2015
Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants
Michael E Thase, James M Youakim, Aleksandar Skuban, et al.
Journal of Affective Disorders
|
November 28, 2017
Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder
Joseph R Calabrese, Raymond Sanchez, Na Jin, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 56) with videos related to
Sort By:
Page
of 6
Journal of Medical Economics
|
May 14, 2013
Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia
John M Kane, Raymond Sanchez, Joan Zhao, et al.
The Journal of Clinical Psychiatry
|
August 25, 2015
Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study
Michael E Thase, James M Youakim, Aleksandar Skuban, et al.
Journal of Medical Economics
|
October 28, 2014
Hospitalization rates in patients switched from oral anti-psychotics to aripiprazole once-monthly: final efficacy analysis
John M Kane, Cathy Zhao, Brian R Johnson, et al.
The Journal of Clinical Psychiatry
|
October 6, 2007
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline
Gary S Sachs, Bruce D Gaulin, Rolando Gutierrez-Esteinou, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
January 2, 2009
Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study
Allan H Young, Dan A Oren, Adam Lowy, et al.
The Journal of Clinical Psychiatry
|
June 16, 2012
Aripiprazole intramuscular depot as maintenance treatment in patients with schizophrenia: a 52-week, multicenter, randomized, double-blind, placebo-controlled study
John M Kane, Raymond Sanchez, Pamela P Perry, et al.
The Journal of Clinical Psychiatry
|
October 27, 2007
Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo
Paul E Keck, Joseph R Calabrese, Roger S McIntyre, et al.
Journal of Clinical Psychopharmacology
|
April 7, 2017
Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores
Zahinoor Ismail, Timothy Peters-Strickland, Maia Miguelez, et al.
The Journal of Clinical Psychiatry
|
August 25, 2015
Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants
Michael E Thase, James M Youakim, Aleksandar Skuban, et al.
Journal of Affective Disorders
|
November 28, 2017
Symptoms and functioning with aripiprazole once-monthly injection as maintenance treatment for bipolar I disorder
Joseph R Calabrese, Raymond Sanchez, Na Jin, et al.
Page
of 6